Free Newsletter
Chinese made-in-India fakes seized by regulators
India, with help from Nigeria, has made one of its largest scores this year of Chinese-origin "Made in India" fakes: about $220,000 of VS International's antibiotic Ciprotab. The counterfeits, which contained little or no API, traveled through Frankfurt to Nigeria, where they were seized by regulators. Article
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: